GV-150013X

Catalog No. :
ACWVKM956
CAS No. :
151386-96-8
Molecular Formula :
C33H34N4O3
Molecular Weight :
534.66

IUPAC Name:(S)-1-(1-(adamantan-1-ylmethyl)-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl)-3-phenylurea

GV-150013X structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1mg95%$84.00Login to see priceInquiryInquiry
5mg95%$202.00Login to see priceInquiryInquiry
10mg95%$281.00Login to see priceInquiryInquiry
25mg95%$414.00Login to see priceInquiryInquiry
50mg95%$562.00Login to see priceInquiryInquiry
100mg95%$744.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameGV-150013X
IUPAC Name(S)-1-(1-(adamantan-1-ylmethyl)-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl)-3-phenylurea
Molecular FormulaC33H34N4O3
Molecular Weight534.66
SMILESC(C12CC3CC(C1)CC(C2)C3)N4C=5C(N(C(=O)[C@@H](NC(NC6=CC=CC=C6)=O)C4=O)C7=CC=CC=C7)=CC=CC5
InChI KeyRZERRLOTRSJIAW-NGYFYKNKSA-N
SynonymUrea, N-phenyl-N'-[(3S)-2,3,4,5-tetrahydro-2,4-dioxo-1-phenyl-5-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-1H-1,5-benzodiazepin-3-yl]-;(S)-1-(1-(adamantan-1-ylmethyl)-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl)-3-phenylurea;GV-150013X, 10 mM in DMSO
CAS No.151386-96-8

Synthetic Route by SureRoute

1. ACWVKM956 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWVKM956 route product structure diagram
    ACWVKM956151386-96-8
Inquiry

2. ACWVKM956 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWVKM956 route product structure diagram
    ACWVKM956151386-96-8
Inquiry

Comments (0)